Personalized care for urologic cancer based on gut and urine bacteria
Treatments studied
Part of Cancer, Infections, Kidney & urinary clinical trials.
This study looks at how your body’s bacteria (microbiome in and around the urinary/genital area) may help guide personalized treatment for localized urologic cancers. The goal is to see whether tailoring treatment to your bacteria could improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of a urologic (urinary/genital) cancer from a biopsy
- Your cancer is localized (not spread widely)
- You have not been hospitalized within the last 3 months after surgery
- You have not taken antibiotics within the last 3 months after surgery
- You have not had an infection such as a urinary tract infection within the last 3 months after surgery
- You do not have diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a personalized antibiotic approach before surgery can reduce infections compared to the usual one-size-fits-all antibiotics. It focuses on people having their bladder removed (cystectomy) with a specific type of urinary diversion.
This study looks at the bacteria in your gut and bladder to understand how they may relate to bladder cancer. It is for men who are having their first tumor removal for suspected bladder cancer, and helps researchers learn if the microbiome plays a role.
This study looks at the bacteria in your body (microbiome) to see if they can help predict how your bladder cancer will progress. It aims to find patterns that might guide better treatment decisions.
This study looks at bacteria in urine and the bladder to understand if they play a role in causing bladder cancer. Researchers will compare samples from men with bladder cancer and healthy controls.
This study compares the bacteria in urine of men with bladder cancer to those with other urinary issues and healthy men. For bladder cancer patients, it looks at differences before a planned surgery to remove the bladder.
This trial tests whether a specific urine test result can help doctors safely avoid using strong, broad-spectrum antibiotics in patients with urinary tract infections. It aims to reduce unnecessary antibiotic use while still treating the infection effectively.
Hear when a new Microbial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.